37
Views
6
CrossRef citations to date
0
Altmetric
Drug Evaluation

Letrozole for the management of breast cancer

&
Pages 249-260 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Dieter Koeberle & Beat Thuerlimann. (2006) Letrozole as adjuvant endocrine therapy in postmenopausal women with breast cancer. Expert Review of Anticancer Therapy 6:1, pages 5-10.
Read now

Articles from other publishers (5)

Shanshan Chen, Lan Bo, Dan Lv & Fei Ma. (2022) Bone Safety Profile of Steroidal Aromatase Inhibitor in Comparison to Nonsteroidal Aromatase Inhibitors in Postmenopausal Women with Breast Cancer: A Network Meta-Analysis. Breast Care 17:4, pages 391-402.
Crossref
Maria Almira Correia & Paul. F. Hollenberg. 2015. Cytochrome P450. Cytochrome P450 177 259 .
Maria Almira Correia & Paul R. Ortiz de Montellano. 2005. Cytochrome P450. Cytochrome P450 247 322 .
Paul E. Goss, Shangle Qi, Angela M. Cheung, Haiqing Hu, Maria Mendes & Kenneth P. H. Pritzker. (2004) Effects of the Steroidal Aromatase Inhibitor Exemestane and the Nonsteroidal Aromatase Inhibitor Letrozole on Bone and Lipid Metabolism in Ovariectomized Rats. Clinical Cancer Research 10:17, pages 5717-5723.
Crossref
Zhi-Jian Liu & Bao Ting Zhu. (2004) Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology 88:3, pages 265-275.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.